{
    "clinical_study": {
        "@rank": "137942", 
        "arm_group": [
            {
                "arm_group_label": "Arm A (aerobic and exercise training)", 
                "arm_group_type": "Experimental", 
                "description": "Patients and their support persons undergo a supervised combined aerobic exercise comprising walking, cycling, or video-based aerobics and strength training using resistance bands for 40 minutes 2 days a week at the UWHC and 3 days a week at home over 8 weeks."
            }, 
            {
                "arm_group_label": "Arm II (usual care)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients and their support persons undergo the usual care over 8 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized pilot clinical trial studies exercise intervention in improving quality of\n      life and exercise capacity and reducing inflammation and oxidative stress in patients with\n      lung cancer and their support persons. Exercise therapy may help improve quality of life,\n      may increase exercise capacity, and may reduce inflammation and oxidative stress in patients\n      with lung cancer and their supporters."
        }, 
        "brief_title": "Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients", 
        "condition": [
            "Extensive Stage Small Cell Lung Cancer", 
            "Healthy, no Evidence of Disease", 
            "Limited Stage Small Cell Lung Cancer", 
            "Recurrent Non-small Cell Lung Cancer", 
            "Recurrent Small Cell Lung Cancer", 
            "Stage IA Non-small Cell Lung Cancer", 
            "Stage IB Non-small Cell Lung Cancer", 
            "Stage IIA Non-small Cell Lung Cancer", 
            "Stage IIB Non-small Cell Lung Cancer", 
            "Stage IIIA Non-small Cell Lung Cancer", 
            "Stage IIIB Non-small Cell Lung Cancer", 
            "Stage IV Non-small Cell Lung Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms", 
                "Small Cell Lung Carcinoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. Determine the effect of an eight-week exercise intervention on biomarkers of\n      inflammation, oxidative stress, exercise capacity, and quality of life in lung cancer\n      patients.\n\n      SECONDARY OBJECTIVES:\n\n      I. Determine the effect of an eight-week exercise intervention on markers of stress and\n      quality of life in the support person of lung cancer patients.\n\n      OUTLINE: Participants are randomized to 1 of 2 arms.\n\n      ARM A: Patients and their support persons undergo a supervised combined aerobic exercise\n      comprising walking, cycling, or video-based aerobics and strength training using resistance\n      bands for 40 minutes 2 days a week at the University of Wisconsin Hospital and Clinic (UWHC)\n      and 3 days a week at home over 8 weeks.\n\n      ARM B: Patients and their support persons undergo the usual care over 8 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  LUNG CANCER PATIENTS: A confirmed diagnosis of any stage lung cancer (non-small cell\n             lung cancer [NSCLC] or small cell lung cancer [SCLC])\n\n          -  LUNG CANCER PATIENTS: Can be receiving any type of treatment (chemotherapy, radiation\n             therapy, both or neither) are eligible\n\n          -  LUNG CANCER PATIENTS: Able to understand and read in English sufficiently to\n             adequately complete informed consent to participate and to complete the\n             questionnaires\n\n          -  LUNG CANCER PATIENTS: For patients treated with curative intent, and who have not\n             relapsed, they must be within 1 year of their diagnosis of lung cancer (determined by\n             date of diagnostic pathology sample)\n\n          -  SUPPORT PERSONS: Able to understand and read in English sufficiently to adequately\n             complete informed consent to participate and to complete the questionnaires\n\n        Exclusion Criteria:\n\n          -  LUNG CANCER PATIENTS: Symptomatic heart disease including congestive heart failure or\n             arrhythmia\n\n          -  LUNG CANCER PATIENTS: Documented myocardial infarction in the last three months\n\n          -  LUNG CANCER PATIENTS: Central nervous system (CNS) metastases that results in\n             impaired ability to participate in an exercise program at the discretion of the study\n             physician\n\n          -  LUNG CANCER PATIENTS: Any psychological or physical disease that would impair or\n             prevent participation in an exercise program at the discretion of the study physician\n\n          -  LUNG CANCER PATIENTS: Cognitive or reading impairments that would preclude them from\n             completing questionnaires\n\n          -  LUNG CANCER PATIENTS: Current participation in an exercise program\n\n          -  SUPPORT PERSONS: Symptomatic heart disease including congestive heart failure or\n             arrhythmia\n\n          -  SUPPORT PERSONS: Documented myocardial infarction in the last three months\n\n          -  SUPPORT PERSONS: Cognitive or reading impairments that would preclude them from\n             completing questionnaires"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01999881", 
            "org_study_id": "UW13034", 
            "secondary_id": [
                "NCI-2013-02185", 
                "2013-0752", 
                "UW13034", 
                "P30CA014520"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm A (aerobic and exercise training)", 
                "description": "Receive aerobic and exercise intervention", 
                "intervention_name": "exercise intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Arm II (usual care)", 
                "description": "Receive usual care", 
                "intervention_name": "standard follow-up care", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Arm A (aerobic and exercise training)", 
                    "Arm II (usual care)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }, 
            {
                "arm_group_label": [
                    "Arm A (aerobic and exercise training)", 
                    "Arm II (usual care)"
                ], 
                "description": "Correlative studies", 
                "intervention_name": "laboratory biomarker analysis", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 18, 2014", 
        "location": [
            {
                "contact": {
                    "email": "robert.hegeman@uwmf.wisc.edu", 
                    "last_name": "Robert B. Hegeman", 
                    "phone": "608-287-2552"
                }, 
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53715"
                    }, 
                    "name": "UW Health Oncology - 1 South Park"
                }, 
                "investigator": {
                    "last_name": "Robert B. Hegeman", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tcc@medicine.wisc.edu", 
                    "last_name": "Toby C. Campbell", 
                    "phone": "608-263-9823"
                }, 
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53792"
                    }, 
                    "name": "University of Wisconsin, Madison"
                }, 
                "investigator": {
                    "last_name": "Toby C. Campbell", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients", 
        "overall_contact": {
            "email": "tcc@medicine.wisc.edu", 
            "last_name": "Toby Campbell, MD", 
            "phone": "608-263-3962"
        }, 
        "overall_contact_backup": {
            "email": "hrhernan@medicine.wisc.edu", 
            "last_name": "Hilary Hernan", 
            "phone": "608-262-8158"
        }, 
        "overall_official": {
            "affiliation": "University of Wisconsin, Madison", 
            "last_name": "Toby Campbell", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in biomarkers of inflammation", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }, 
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in oxidative damage as indicated by serum 8-hydroxydeoxyguanosine (8-oh-dG)", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }, 
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in time to walk 400 m", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }, 
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in physical well-being scores on the Functional Assessment of Cancer Therapy-Lung (FACT-L)", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }, 
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in functional well-being scores on the FACT-L", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01999881"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in stress scores on the SF-36", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }, 
            {
                "description": "Descriptive statistics will be calculated and compared between the two treatment groups at baseline using unpaired t-tests and Chi-Square analyses. A two-way analysis of variance will be used to examine the effects of the treatment over time.", 
                "measure": "Change in quality-of-life scores on the SF-36", 
                "safety_issue": "No", 
                "time_frame": "Baseline up to 8 weeks"
            }
        ], 
        "source": "University of Wisconsin, Madison", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Wisconsin, Madison", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}